Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Factor XIII Replacement in Postpartum Hemorrhage
NCT06481995Phase 4Recruiting
- Start
- Jul 2024
- Primary completion
- Jun 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of catridecacog in postpartum hemorrhage (PPH). Started Jul 2024; status: recruiting.
02
Drugs
catridecacog
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT06481995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06481995.